Drug trial aims to stop deadly viruses before they take hold
NCT ID NCT06682234
Summary
This study aimed to test if a drug called obeldesivir could safely prevent Ebola or Marburg virus disease in people who had recently been exposed to these viruses. It was designed for people who had high-risk contact with an infected person or their bodily fluids. The trial was withdrawn by the sponsor before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FILOVIRUS DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.